Impact of Gonadotropin-Releasing Hormone Antagonist vs Agonist on Clinical Safety and Oncologic Outcomes on Patients With Metastatic Prostate Cancer

Written by Marc B Garnick MD

Read the full article here

Source: PracticeUpdate
Categories: General Medicine News, Latest Headlines
Tags:
Tweets with this article
PracticeUpdate
Impact of Gonadotropin-Releasing Hormone Antagonist vs Agonist on Clinical Safety and Oncologic Outcomes on Patients With Metastatic #ProstateCancer. Commentary by Marc B Garnick MD https://t.co/m3f98uFPbc

Related Articles